Back to search results

Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

Abroad (travel likely)RecruitingPHASE3

Conditions

Pseudomyxoma Peritonei

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Peritoneal Malignancy Institute Basingstoke - Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, United Kingdom

    Contact: Study coordinator (Faheez Mohamed) · Faheez.Mohamed@hhft.nhs.uk
    Contact: Study coordinator (Sophia Stanford) · sophia.stanford@hhft.nhs.uk
    Contact: Principal Investigator (Faheez Mohamed)
    Sophia Stanford (Sub-investigator)
    Alexios Tzivanakis (Sub-investigator)
    Tom Cecil (Sub-investigator)
    Sanjeev Dayal (Sub-investigator)
    Gui Han Lee (Sub-investigator)
    Brendan Moran (Sub-investigator)
    Vasanth Mark Samuel (Sub-investigator)
Study leads

  • Faheez Mohamed, MBChB, MD, FRCS

    Principal Investigator

    Peritoneal Malignancy Unit Hampshire Hospitals NHS Foundation Trust

View source on ClinicalTrials.gov(opens in a new tab)